Research, Education, and Outreach on Botanical Natural Products
🏛 Food and Drug Administration (HHS-FDA)
✓ Free, no account · Source: Grants.gov · Last verified Jul 27, 2026
Can you apply?
This grant is for botanical natural products research, education, and outreach in collaboration with the FDA. Only the University of Mississippi is eligible to apply. The program supports identification and validation of botanical ingredients in foods, dietary supplements, and cosmetics. Activities include developing reference materials, exchanging scientific information with FDA, and coordinating workshops on botanical topics relevant to public health.
The funding focuses on safety assessment of botanical products. Eligible work includes acquiring authenticated plant materials and purified natural products. Collaboration with FDA scientists in mutual research areas is expected.
Not the right fit? Find grants for your organization in 5 questions →
Program description
The purpose of this funding opportunity is to provide continued support to: (1) assist in the identification and development of a prioritized list of botanical ingredients based on safety concerns, trends and knowledge of botanical ingredients in foods, dietary supplements, and cosmetics marketed in the U.S.; (2) acquire, validate and characterize authenticated reference materials, including raw and processed plant materials and purified natural products of relevance to FDA for evaluation of safety; (3) exchange technical and scientific information, methods and reference material with FDA scientists and other stakeholders; (4) collaborate with FDA scientists in research areas of mutual interest; (5) coordinate scientific workshops, training and conferences on botanical topics of public health relevance to address high priority science and research needs.
Who can apply
Eligible applicants
How to apply
Application links
Key dates & requirements
Required documents
- SF-424 Federal Grant Application
- Project Narrative with research plan
- Budget and Budget Justification
- Letters of Support from FDA collaborators
- Curriculum Vitae for Key Personnel
- Institutional Commitment Letter
Program contact
- 👤 Stephanie Bogan Grantor
- 📧 patrick.johnson@fda.hhs.gov
- 📞 3018276802
Funding track record
Recent awards under CFDA 93.103 from the last 3 years — real organizations that won funding through this same program.
Top 10 Largest Recent Awards
-
$121,795,918
-
$76,105,626
-
$50,217,964
-
$47,940,304
-
$36,000,000
-
$35,573,997
-
$35,391,995
-
$30,732,300
-
$24,423,552
-
$23,332,999
Top States by Funding
- AZ 4 awards $134.7M
- CA 9 awards $111.3M
- MD 7 awards $108.8M
- VA 5 awards $96.6M
- PA 10 awards $77.4M
Source: USAspending.gov — federal spending transparency. Data covers last 3 years.
Funding history
Annual funding for this program — Federal obligations (CFDA 93.103). How funding has trended year over year.
| 2016 | $170,482,435 | |
| 2017 est. | $208,900,832 | |
| 2018 | $173,077,408 | |
| 2019 | $198,507,896 | |
| 2020 | $212,448,590 | |
| 2021 | $218,918,739 | |
| 2022 est. | $255,910,458 | |
| 2023 est. | $246,894,600 |
FAQ
Who can apply for this grant?
Only the University of Mississippi is eligible. This is a single-source funding opportunity restricted to this institution.
What activities are supported?
The grant supports botanical ingredient identification, development of reference materials, research collaboration with FDA scientists, and scientific workshops on botanical safety topics.
Is there a deadline?
Yes, the deadline is August 21, 2026. This is a fixed deadline, not rolling.
What is the funding amount?
The award can reach up to $5,100,000. Specific amounts vary based on project scope and FDA priorities.
Is cost-sharing required?
No, cost-sharing is not required for this grant. All eligible project costs can be covered by the award.
💡 Tips for applicants
- Focus on collaborative research areas with FDA scientists. Alignment with agency priorities increases competitiveness significantly.
- Develop detailed plans for acquiring and validating botanical reference materials. These materials are central to the grant's goals.
- Emphasize public health relevance in your research. The FDA prioritizes work addressing safety concerns in foods and supplements.
- Plan clear dissemination through workshops, training, and conferences. The grant values scientific knowledge sharing with stakeholders.
- Build strong partnerships with FDA collaborators before submitting. Pre-existing relationships demonstrate feasibility and commitment.
⚠️ Common mistakes
Applicants fail to establish prior collaboration with FDA scientists, which signals low likelihood of productive partnership. Proposals lack clear reference material validation protocols or authentication methods for botanical samples. Projects that emphasize basic research over public health impact miss the FDA's mission-driven focus.
Similar grants
- ROLLING Educational Funding Opportunity: Expanding education on skin lightening products (U01) Clinical Trials Not Allowed — Food and Drug Administration
- ROLLING OMHHE Educational Funding Opportunity: Expanding education on skin lightening products (U01) Clinical Trials Not Allowed — Food and Drug Administration
- ROLLING FDA’s Integrated Food Safety System Training Delivery and Development — Food and Drug Administration
- OPEN Reissue of RFA-FD-23-001- Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases (R01 Clinical Trials Required) — Food and Drug Administration
- OPEN NCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award (R61/R33 Clinical Trial Required) — National Institutes of Health